These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Conservative treatment of staphylococcal prosthetic joint infections in elderly patients. Barberán J, Aguilar L, Carroquino G, Giménez MJ, Sánchez B, Martínez D, Prieto J. Am J Med; 2006 Nov; 119(11):993.e7-10. PubMed ID: 17071171 [Abstract] [Full Text] [Related]
6. Daptomycin therapy for invasive Gram-positive bacterial infections in children. Ardura MI, Mejías A, Katz KS, Revell P, McCracken GH, Sánchez PJ. Pediatr Infect Dis J; 2007 Dec; 26(12):1128-32. PubMed ID: 18043450 [Abstract] [Full Text] [Related]
7. High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis. Durante-Mangoni E, Casillo R, Bernardo M, Caianiello C, Mattucci I, Pinto D, Agrusta F, Caprioli R, Albisinni R, Ragone E, Utili R. Clin Infect Dis; 2012 Feb 01; 54(3):347-54. PubMed ID: 22100575 [Abstract] [Full Text] [Related]
8. Efficacy of daptomycin in complicated skin and skin-structure infections due to methicillin-sensitive and -resistant Staphylococcus aureus: results from the CORE Registry. Martone WJ, Lamp KC. Curr Med Res Opin; 2006 Dec 01; 22(12):2337-43. PubMed ID: 17257448 [Abstract] [Full Text] [Related]
9. Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy. Moise PA, Hershberger E, Amodio-Groton MI, Lamp KC. Ann Pharmacother; 2009 Jul 01; 43(7):1211-9. PubMed ID: 19584384 [Abstract] [Full Text] [Related]
10. Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: a retrospective case series of 31 patients. Segreti JA, Crank CW, Finney MS. Pharmacotherapy; 2006 Mar 01; 26(3):347-52. PubMed ID: 16503714 [Abstract] [Full Text] [Related]
11. Use of antibiotic-loaded polymethylmethacrylate beads for the treatment of extracavitary prosthetic vascular graft infections. Stone PA, Armstrong PA, Bandyk DF, Brumberg RS, Flaherty SK, Back MR, Johnson BL, Shames ML. J Vasc Surg; 2006 Oct 01; 44(4):757-61. PubMed ID: 17012000 [Abstract] [Full Text] [Related]
12. Efficacy and safety of linezolid for Gram-positive orthopedic infections: a prospective case series. Rao N, Hamilton CW. Diagn Microbiol Infect Dis; 2007 Oct 01; 59(2):173-9. PubMed ID: 17574788 [Abstract] [Full Text] [Related]
14. Clinical experience with daptomycin for the treatment of patients with knee and hip periprosthetic joint infections. Corona Pérez-Cardona PS, Barro Ojeda V, Rodriguez Pardo D, Pigrau Serrallach C, Guerra Farfán E, Amat Mateu C, Flores Sanchez X. J Antimicrob Chemother; 2012 Jul 01; 67(7):1749-54. PubMed ID: 22511636 [Abstract] [Full Text] [Related]
15. Outcomes with daptomycin versus standard therapy for osteoarticular infections associated with Staphylococcus aureus bacteraemia. Lalani T, Boucher HW, Cosgrove SE, Fowler VG, Kanafani ZA, Vigliani GA, Campion M, Abrutyn E, Levine DP, Price CS, Rehm SJ, Corey GR, Karchmer AW, S. aureus Endocarditis and Bacteraemia Study Group. J Antimicrob Chemother; 2008 Jan 01; 61(1):177-82. PubMed ID: 17999973 [Abstract] [Full Text] [Related]
16. The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria. Rybak MJ. Clin Microbiol Infect; 2006 Mar 01; 12 Suppl 1():24-32. PubMed ID: 16445721 [Abstract] [Full Text] [Related]
17. A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria. Katz DE, Lindfield KC, Steenbergen JN, Benziger DP, Blackerby KJ, Knapp AG, Martone WJ. Int J Clin Pract; 2008 Sep 01; 62(9):1455-64. PubMed ID: 18662172 [Abstract] [Full Text] [Related]
18. Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients. Chaftari AM, Hachem R, Mulanovich V, Chemaly RF, Adachi J, Jacobson K, Jiang Y, Raad I. Int J Antimicrob Agents; 2010 Aug 01; 36(2):182-6. PubMed ID: 20452752 [Abstract] [Full Text] [Related]
19. Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin. French GL. J Antimicrob Chemother; 2006 Dec 01; 58(6):1107-17. PubMed ID: 17040922 [Abstract] [Full Text] [Related]
20. In vitro activity of daptomycin and tigecycline against coagulase-negative staphylococcus blood isolates from bone marrow transplant recipients. Kratzer C, Rabitsch W, Hirschl AM, Graninger W, Presterl E. Eur J Haematol; 2007 Nov 01; 79(5):405-9. PubMed ID: 17714506 [Abstract] [Full Text] [Related] Page: [Next] [New Search]